Syros earnings
WebApr 12, 2024 · Myelodysplastic Syndrome Epidemiology Insights. The total incident population of MDS in the 7MM was 41,850 in 2024, growing at a CAGR of 0.6% during the study period (2024–2032). WebAug 9, 2024 · Syros Pharmaceuticals, Inc. (SYRS) CEO Nancy Simonian on Q2 2024 Results - Earnings Call Transcript Aug. 09, 2024 2:29 PM ET Syros Pharmaceuticals, Inc. (SYRS) SA Transcripts 134.66K Follower...
Syros earnings
Did you know?
WebSyros Pharmaceuticals, Inc. (SYRS) Latest Stock News & Headlines - Yahoo Finance U.S. markets closed Dow Futures Nasdaq Futures Russell 2000 Futures (+0.25%) Crude Oil Gold Syros... WebMar 1, 2024 · Analysts estimate that Syros Pharmaceuticals will report an earnings per share (EPS) of $1.35. Syros Pharmaceuticals bulls will hope to hear the company …
WebMar 2, 2024 · For the full year ended December 31 2024, Syros reported a net loss of $94.7 million or $7.49 per share, compared to a net loss of $86.6 million or $13.84 per share for … Web20 hours ago · SYRS: Syros Pharmaceuticals Detailed Earnings Estimate. Get the latest Detailed Estimate from Zacks Investment Research. SYRS: Syros Pharmaceuticals - …
WebApr 14, 2024 · Syros Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag: Mar 3: Q4 2024 Syros Pharmaceuticals Inc Earnings Call: Mar 2: Syros Pharmaceuticals, Inc. (SYRS) Q4 2024 Earnings Call Transcript: Mar 2: Syros Pharmaceuticals, Inc. (SYRS) Reports Q4 Loss, Lags Revenue Estimates: Mar 2: Syros … WebMar 24, 2024 · Syros Pharmaceuticals (SYRS) (Delayed Data from NSDQ) $2.74 USD -0.07 (-2.49%) Updated Mar 24, 2024 04:00 PM ET After-Market: $2.72 -0.02 (-0.73%) 7:58 PM ET Add to portfolio Zacks Rank: 3-Hold 3...
WebApr 9, 2024 · Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. About the company Rewards Revenue is forecast to grow 58.79% per year Risk Analysis Shareholders have been substantially diluted in the past year
WebSyros Pharmaceuticals said in a filing Monday that it expects its initial public offering of stock to price between $14 and $16 a share. The biopharmaceutical company, which has … flagstar bank in coloradoWebRepresents the company's profit divided by the outstanding shares of its common stock. -0.17. 95.53%. EBITDA. Earnings before interest, taxes, depreciation, and amortization, is a … flagstar bank in fort wayne indianaWebApr 12, 2024 · Myelodysplastic Syndrome Epidemiology Insights. The total incident population of MDS in the 7MM was 41,850 in 2024, growing at a CAGR of 0.6% during the … flagstar bank home officeWebAug 9, 2016 · SYRS - Syros Pharmaceuticals, Inc. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save to portfolio create alert compare perf. Candle - advanced Intraday Daily Weekly Monthly Draw Fullscreen Settings SYRS - Stock Price Chart SYRS [NASD] canon pixma mx490 is it a inkjet printerWebNov 11, 2024 · Syros Pharmaceuticals (SYRS) is scheduled to announce Q3 earnings results on Monday, November 14th, before market open.The consensus EPS Estimate is -$3.83 and the consensus... flagstar bank insurance claimWebAug 9, 2024 · Syros Pharmaceuticals, Inc. is estimated to report earnings on 11/04/2024. The upcoming earnings date is derived from an algorithm based on a company's … flagstar bank holiday scheduleWebMar 2, 2024 · Syros Pharmaceuticals (SYRS) Recent Earnings Syros Pharmaceuticals (SYRS) reported a Quarter December 2024 loss of $1.28 per share on revenue of $0.8 … canon pixma mx475 wireless inkjet printer